
Opinion|Videos|April 17, 2025
Uptake of New Treatments in Urology Practice
Experts discuss their expectations regarding the uptake of new treatments in clinical practice for non–muscle-invasive bladder cancer and other relevant conditions.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What do you anticipate regarding the uptake of new treatments in clinical practices?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
3
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
4
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
5













